We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Need a bigger pond

25 Jul 2005 By Robert Cyran

Giants such as Israel s Teva and Switzerland s Novartis are being forced into buying competitors to offset increasing margin pressure. The problem is the reported price for Ivax 26 times operating profits seems guaranteed to destroy value.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)